» Articles » PMID: 31399034

The Emerging Role of the PiRNA/piwi Complex in Cancer

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2019 Aug 11
PMID 31399034
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Piwi interacting RNAs (piRNAs) constitute novel small non-coding RNA molecules of approximately 24-31 nucleotides in length that often bind to members of the piwi protein family to play regulatory roles. Recently, emerging evidence suggests that in addition to the mammalian germline, piRNAs are also expressed in a tissue-specific manner in a variety of human tissues and modulate key signaling pathways at the transcriptional or post-transcriptional level. In addition, a growing number of studies have shown that piRNA and PIWI proteins, which are abnormally expressed in various cancers, may serve as novel biomarkers and therapeutic targets for tumor diagnostics and treatment. However, the functions of piRNAs in cancer and their underlying mechanisms remain incompletely understood. In this review, we discuss current findings regarding piRNA biogenetic processes, functions, and emerging roles in cancer, providing new insights regarding the potential applications of piRNAs and piwi proteins in cancer diagnosis and clinical treatment.

Citing Articles

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

Qin H, Han Y, Li J, Wu Q, Du Y, Li Q NPJ Precis Oncol. 2025; 9(1):65.

PMID: 40057617 PMC: 11890584. DOI: 10.1038/s41698-025-00840-w.


Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


PIWI-interacting RNA MIABEPIR regulates cerebral endothelial cell function via DAPK2 pathway in offspring following maternal immune activation.

Li S, Guo M, Long Y, Cai Y, Zhao Y, Huang S Clin Transl Med. 2025; 15(3):e70260.

PMID: 40000424 PMC: 11859124. DOI: 10.1002/ctm2.70260.


Small non-coding RNA profiling in patients with non-muscle invasive bladder cancer.

Cai J, Yan Z, Zhong Y, Li Y, Huang J, Hu H BMC Cancer. 2025; 25(1):319.

PMID: 39984879 PMC: 11846270. DOI: 10.1186/s12885-025-13672-5.


Clinical implications of Alu-based cell-free DNA and serum onco-piRNA monitoring in colorectal cancer management.

Taghizadeh-Teymorloei M, Jafarlou V, Matin S, Raeisi M, Roosta Y, Mansouri-Derakhshani S Clin Transl Oncol. 2025; .

PMID: 39969763 DOI: 10.1007/s12094-025-03863-8.


References
1.
Cheng J, Guo J, Xiao B, Miao Y, Jiang Z, Zhou H . piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta. 2011; 412(17-18):1621-5. DOI: 10.1016/j.cca.2011.05.015. View

2.
Cortez M, Calin G . MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009; 9(6):703-711. DOI: 10.1517/14712590902932889. View

3.
Aravin A, Sachidanandam R, Girard A, Fejes-Toth K, Hannon G . Developmentally regulated piRNA clusters implicate MILI in transposon control. Science. 2007; 316(5825):744-7. DOI: 10.1126/science.1142612. View

4.
Peng L, Song L, Liu C, Lv X, Li X, Jie J . piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling. Tumour Biol. 2015; 37(2):2749-56. DOI: 10.1007/s13277-015-4056-0. View

5.
Zeng G, Zhang D, Liu X, Kang Q, Fu Y, Tang B . Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma. Oncotarget. 2016; 8(3):4607-4617. PMC: 5354858. DOI: 10.18632/oncotarget.13491. View